許 惠晴

Medicine & Life Sciences

1. Autoimmune Diseases 100%
2. Sjogren's Syndrome 76%
3. Cohort Studies 68%
4. Rheumatoid Arthritis 49%
5. Population 49%
6. Systemic Lupus Erythematosus 43%
7. Hepacivirus 42%
8. Appendectomy 40%
9. Virus Diseases 36%
10. Thyroiditis 34%
11. Bisphosphonate-Associated Osteonecrosis of the Jaw 33%
12. Gouty Arthritis 33%
13. Thymectomy 29%
14. Pneumocystis Pneumonia 28%
15. Hip Replacement Arthroplasties 26%
16. Atrioventricular Block 26%
17. Histamine Antagonists 26%
18. Comorbidity 25%
19. Proton Pump Inhibitors 25%
20. Allergic Rhinitis 24%
21. Autoimmune Haemolytic Anaemia 24%
22. National Health Programs 24%
23. Osteomyelitis 24%
24. Taiwan 24%
25. Rheumatic Diseases 24%
26. Chronic Hepatitis C 23%
27. Proportional Hazards Models 23%
28. Knee Replacement Arthroplasties 23%
29. Biological Products 22%
30. Hepatitis B virus 21%
31. Interferons 20%
32. Arthritis 19%
33. Parkinson Disease 19%
34. Dementia 18%
35. Hepatocellular Carcinoma 18%
36. Interleukin-6 17%
37. Antibodies 16%
38. Systemic Vasculitis 16%
39. Macrophages 15%
40. Ankylosing Spondylitis 14%
41. Tonsillectomy 14%
42. Addison Disease 13%
43. Databases 12%
44. Myasthenia Gravis 12%
45. Hashimoto Disease 12%
46. Graves Disease 12%
47. Confidence Intervals 11%
48. Infections 10%
49. Retrospective Studies 9%
50. Membranous Glomerulonephritis 9%